Skip to main content

Project ECHO®: Cardiovascular Toxicities
with Immune Checkpoint Inhibitors

Telementoring To Manage Immune-related Adverse Events
in Patients Receiving Cancer Immunotherapies

Session 1 — Cardiology

  • CME Information or Content Source:
    Content Derived from a CME Certified Webinar in September 2022
  • Event Details:
    Program provided by Boston University (BU) and Association of Community Cancer Centers (ACCC)
  • Event Sponsor(s):
    This activity is supported by an educational grant from Bristol Myers Squibb.


Director of Cardio-Oncology, Cardio-Oncology Program, Georgia Cancer Center
Assistant Professor of Medicine, Division of Cardiovascular Disease, Augusta University
An expert in cardiovascular epidemiology pertaining to cardio-oncology

Laura Wood, RN, MSN OCN
Oncology Nurse Specialist, Medina, Ohio

Learning Objectives

At the end of this educational program, participants should be able to:

  • Apply evidence-based practices for the monitoring and management of immune-related adverse events (irAE) in patients receiving cancer immunotherapies
  • Improve coordination and communication with non-oncology specialists and with patients/caregivers to manage irAE in patients receiving cancer immunotherapies
  • Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies

Click here to learn about remaining Project ECHO sessions or to view other available recordings.